Premium
Ibrutinib is a safe and effective therapy for systemic mantle cell lymphoma with central nervous system involvement – a multi‐centre case series from the United Kingdom
Author(s) -
Tucker David L.,
Naylor Georgina,
Kruger Anton,
Hamilton Malcolm S.,
Follows George,
Rule Simon A.
Publication year - 2017
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.14122
Subject(s) - ibrutinib , mantle cell lymphoma , medicine , oncology , tolerability , diffuse large b cell lymphoma , lymphoma , adverse effect , leukemia , chronic lymphocytic leukemia
This article is currently freely available from the publisher's site (May 2016). Click on the 'Additional Link' above to access the full-text from the publisher's site